GlassScriptPhysician profile
Timothy Renzi
NPI 1437774536
$4,237.63
in general payments reported to CMS, 2019-2025
11 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.97 · 2021: $1,330 · 2022: $1,717 · 2023: $527 · 2024: $288 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Solutions LLC | $2,422.27 | 2021-2022 | |
| Stryker Corporation | $957.89 | 2022-2025 | Infinity, Flexband, Variax |
| Axogen | $239.54 | 2022-2025 | |
| Depuy Synthes Sales INC. | $193.33 | 2020-2024 | Na, Motoband, Va-Lcp |
| Medtronic, INC. | $150.00 | 2023 | Prestige LP Cervical Disc System |
| Cerapedics INC. | $72.50 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $67.32 | 2021 | |
| Medical Device Business Services, INC. | $51.72 | 2024 | Attune |
| Zimmer Biomet Holdings, INC. | $40.00 | 2021 | |
| Abbvie INC. | $28.17 | 2025 | |
| Solventum Corporation | $14.89 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Renzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.